共 210 条
[1]
Cetin Karynsa(2010)Recent Time Trends in the Epidemiology of Stage IV Prostate Cancer in the United States: Analysis of Data From the Surveillance, Epidemiology, and End Results Program* Urology 75 1396-1404
[2]
Beebe-Dimmer Jennifer L.(2017)Prostate Cancer EAU Guidelines 2017 Eur Urol 17 618-629
[3]
Fryzek Jon P.(2014)Removal of limited nodal disease in patients undergoing radical prostatectomy: long-term results confirm a chance for cure J Urol 191 1280-1285
[4]
Markus Richard(2015)More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer Eur Urol 67 212-219
[5]
Carducci Michael A.(2016)The rise of PSMA ligands for diagnosis and therapy of prostate cancer J Nucl Med 57 79S-89S
[6]
Mottet N(2013)PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer Eur J Nucl Med Mol Imaging 40 1629-1630
[7]
Bellmunt J(2014)Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer Eur J Nucl Med Mol Imaging 41 11-20
[8]
Representative EBP(2016)Initial experience of 68Ga-PSMA PET/CT imaging in high-risk prostate cancer patients prior to radical prostatectomy Eur Urol 69 393-396
[9]
Bolla M(2018)Efficacy, predictive factors, and prediction nomograms for (68)Ga-labeled prostate-specific membrane antigen-ligand positron-emission tomography/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy Eur Urol 73 656-661
[10]
Bourke L(2018)(68)Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review World J Urol 36 519-527